Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
7.35
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed

Actuate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
171155--
Enterprise Value
154142--
Last Close Price
7.357.96--
PB Ratio
15.621492.25--
P/TBV Ratio
15.621492.25--
Quick Ratio
2.660.980.434.71
Current Ratio
2.741.050.434.71
Return on Equity (ROE)
-296.04%--442.40%-
Return on Assets (ROA)
-95.25%-255.41%-132.96%-
Return on Capital (ROIC)
-186.91%--279.06%-
Return on Capital Employed (ROCE)
-214.80%-4876.60%636.30%-125.20%
Earnings Yield
-14.12%-17.55%--
Buyback Yield / Dilution
-418.68%-483.48%-18.54%-
Source: S&P Capital IQ. Standard template. Financial Sources.